Maryland SB 498: Prescription Drug Monitoring Program - Disclosure of Data - Managed Care Organizations

Status: Unfavorable Report by Finance; Withdrawn (as of 2019-03-15)

State: Maryland · Session: 2019 · Bill: SB 498

Subjects: Public Health, Committees and Commissions, Communications, Data, Disclosure, Drugs, Examinations, Federal Government, Health Occupations, Investigations and Inquiries, Law Enforcement, Licenses, Managed Care Organizations, Medical Assistance, Medical Treatments, Opioids, Patients, Pharmacists and Pharmacies, Physicians, Privacy, Rules and Regulations, Subpoenas

Sponsors: Hayes

View Maryland SB 498 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.